2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Long-Term Impact of CMV Infection on the Allograft and on Patient Survival in Renal Transplant Patients with Protocol Biopsies

U. Erdbruegger, I. Scheffner, M. Mengel, A. Schwarz, H. Haller, W. Gwinner
Long-Term Impact of Recipient and Donor Weight on Simultaneous Pancreas / Kidney (SPK) Graft Function

A. Gruessner, R. Gruessner
Long-Term Outcomes after Liver Transplantation for Wilson Disease: A Single-Center Experience

J. Lai, M. Schilsky, T. Schiano, A. Shirsat, J. Chu, R. Arnon
Long-Term Outcomes Following Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis

P. Clayton, S. McDonald, G. Russ, S. Chadban
Long-Term Outcomes of Liver Transplant Patients with HIV-1 Infection: a 14-Year Single-Center Clinical Experience

S. Yamamoto, R. Schwarcz, O. Weiland, A. Oksanen, A. Wernersson, G. Söderdahl, A. Sönnerborg, B. Ericzon
Long-Term Outcomes of Older Adults after Liver Transplantation in the MELD Era

M. Malinis, S. Chen, H. Allore, V. Quagliarello
Long-Term Persistence of Recipient MHC Class-II Antigen Following Allogeneic Bone Marrow Transplantation

T. Brennan, L. Lin, Y. Yang
Long-Term Quality of Life Following Living Kidney Donation

N. Siparsky, O. Glotzer, T. Singh, M. Gallichio, D. Conti
Long-Term Risk of ESRD Attributable to Live Kidney Donation: Matching with Healthy Non-Donors

A. Muzaale, A. Massie, J. Wainright, M. McBride, M. Wang, D. Segev
Long-Term Safety and Effectiveness of Inhibitors of the Mammalian Target of Rapamycin in De Novo Kidney Transplantation: 10 Years of a Single Center Experience

M. Paula, P. Hannun, C. Felipe, H. Tedesco, J. Medina- Pestana

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z